Kun Deng
Impact in
-
- MicroRNA in disease regulation
-
- Extracellular vesicles in disease
- Advanced biosensing and bioanalysis techniques
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Epigenetics and DNA Methylation 3
- Extracellular vesicles in disease 3
-
- Ferroptosis and cancer prognosis 2
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- Yang Liu (2 shared papers)Yan Li (2 shared papers)Yong Zhang (2 shared papers)Xiaoyao Wang (2 shared papers)Dong Zeng (2 shared papers)Lili Zhao (1 shared paper)Zhaoyue Wang (1 shared paper)Rong Yan (1 shared paper)
In The Last Decade
Kun Deng
13 papers receiving 125 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 24
- Molecular Biology 67
- Nephrology 6
- Molecular Medicine 4
- Biomedical Engineering 33
Countries citing papers authored by Kun Deng
This map shows the geographic impact of Kun Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Deng more than expected).
Fields of papers citing papers by Kun Deng
This network shows the impact of papers produced by Kun Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Deng. The network helps show where Kun Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Kun Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 42 | |
| 2 | 2014 | 13 | |
| 3 | 2021 | 13 | |
| 4 | 2021 | 11 | |
| 5 | 2024 | 9 | |
| 6 | 2024 | 8 | |
| 7 | 2021 | 8 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 6 | |
| 10 | 2022 | 4 | |
| 11 | 2023 | 2 | |
| 12 | 2025 | 1 | |
| 13 | 2023 | 1 | |
| 14 | 2024 | 0 | |
| 15 | 2020 | 0 | |
| 16 | 2024 | 0 |
About Kun Deng
Kun Deng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Otorhinolaryngology, having authored 16 papers that have together received 125 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Extracellular vesicles in disease (3 papers), Nanopore and Nanochannel Transport Studies (2 papers), Ferroptosis and cancer prognosis (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Head and Neck Cancer Studies (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (24 citations), Molecular Biology (67 citations), Nephrology (6 citations), Molecular Medicine (4 citations) and Biomedical Engineering (33 citations). Kun Deng has collaborated with scholars based in China, Oman and Uganda. Frequent co-authors include Yang Liu, Yan Li, Yong Zhang, Xiaoyao Wang, Dong Zeng, Lili Zhao, Zhaoyue Wang, Rong Yan, Ming Li and Kesheng Dai. Their work appears in journals such as Bioscience Reports, Advanced Materials Technologies, Renal Failure, Sensors and Actuators B Chemical and Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.